Filing Flows › Nexgel (NXGL) › Q4 2024
Nexgel (NXGL) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 27, 2025
Nexgel (NXGL) reported revenue of $3.0M for the fourth quarter 2024 (Q4 2024), +181% from a year earlier and +3% from the quarter before. Operating margin was -27.7%, net loss $824K (27.1% of revenue).
Nexgel, Q4 2024: revenue $3.0M (+181% year over year), operating margin -27.7%, net loss $824K, operating cash flow −$859K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | +3% | +181% |
| Operating profit | −$841K | — | — |
| Net earnings | −$824K | — | — |
| Operating cash flow | −$859K | — | — |
What changed
Revenue was $3.0M in Q4 2024, up 181% year over year and up 3% from the previous quarter.
Gross margin was 25.6%. Operating costs exceeded revenue by $841K, an operating margin of -27.7%. The quarter ended with a net loss of $824K, wider than the previous quarter's $754K loss.
Operating cash flow was −$859K. Non-cash charges added back $108K of depreciation and amortization and $96K of share-based compensation. Working capital and other items used $239K. Capital expenditures of $69K exceeded it, leaving free cash flow of −$928K.
Questions
What was Nexgel's revenue in the fourth quarter 2024?
Nexgel (NXGL) reported revenue of $3.0M for the fourth quarter 2024 (Q4 2024), +181% from a year earlier and +3% from the quarter before.
Was Nexgel profitable in the fourth quarter 2024?
Operating loss was $841K (-27.7% of revenue) and net loss $824K.
Source: Nexgel 10-K on SEC EDGAR.